MedPath

The effect of two types of interactive and non-interactive short message service on adherence to treatment in patients with hypertensio

Not Applicable
Conditions
I10-I15
Hypertensive diseases
Hypertension.
Registration Number
IRCT20190120042423N1
Lead Sponsor
Artesh University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
63
Inclusion Criteria

A clinical diagnosis of hypertension and either currently receiving antihypertensive medication for at least a one month
A systolic blood pressure 140-220 mmHg and a diastolic blood pressure 90-120 mmHg at enrolment.
Aged 35-64 years
Own or have daily access to a cellphone with able to send a SMS text-message
Able to use the text messaging function (reading and composing a text message)
Able to send and receive a SMS text-message
Do not live in a household where another member has been recruited into the trial
Currently residing in the trial area and expecting to be resident for the duration of the trial
Lack of other diseases requires taking drugs other than anti-hypertensive drugs, such as diabetes
Lack of use complementary therapies such as taking herbal medicines during the study
Not having a history of known heart disease, such as myocardial infarction
Lack of dementia, impaired short-term memory, mental and psychological problems, end-stage liver or kidney disease and cancer
Willing to participate in the study

Exclusion Criteria

Patients whose regimen has changed for two months or more according to the physician's order
Unwillingness to continue cooperation
Pregnancy or lactation during the test for female participants

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence to treatment. Timepoint: Start of study and 4 months after intervention. Method of measurement: Treatment adherence questionnaire for patients with hypertension (TAQPH).;Blood Pressure. Timepoint: Start of study and 1, 2, 3 and 4 months after intervention. Method of measurement: Beurer GmbH, Söflinger Str. 218, 89077 Ulm, Germany, Type: BM16, Item No: 652.02.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath